MRMD Q3 FY26 earnings call: key takeaways

• MeriMed reported record revenue of $44.2 million for the third quarter of 2026, the highest in the company's history, with growth in both wholesale and retail segments (19:47)
• The company emphasized strong brand performance and operational efficiency, with adjusted EBITDA rising 18% sequentially. (19:47)

What changed since last quarter

• The company raised its focus on expanding brand market share and leveraging its strong cash position for future growth. (11:12)
• Mario Pinho highlighted that adjusted gross margin was held flat despite pressure from price compression and higher input costs. (19:47)
• The CFO emphasized the importance of operating leverage and converting revenue growth into higher margins and cash generation. (23:33)

What analysts pressed on

• How the company plans to improve margins given its heavy wholesale mix and high competition in key markets. (39:05)
• Concerns about the impact of new store licenses in Maryland and increased competition in the state. (31:47)

In their words

• We generated the highest quarter... revenue in our history John (11:12)
• We're so grateful that the citizens here sent a resounding no on question eight Ryan Crandall (14:23)
• Our objective isn't changed. To convert revenue growth into higher margin Mario Pinho (23:33)
• We're looking for the best of our ability to bring the share price and the value to the shareholders first (34:38)